hiv
infect
central
nervou
system
cn
primari
infect
persist
resid
macrophag
cn
infect
initi
strong
local
immun
respons
fail
control
viru
respons
bystand
lesion
involv
neurocognit
disord
although
highli
activ
antiretrovir
therapi
offer
almost
complet
control
cn
viral
prolifer
lowgrad
cn
inflamm
persist
review
focus
hivinduc
intrathec
immunoglobulin
ig
synthesi
intrathec
ig
synthesi
earli
occur
threequart
patient
respons
viral
infect
cn
persist
throughout
cours
diseas
viral
antigen
target
specif
respons
account
whole
intrathec
synthesi
although
natur
mechan
lead
nonspecif
synthesi
unknown
promin
proport
compar
observ
variou
cn
viral
infect
cerebrospin
fluidfloat
antibodysecret
cell
account
minor
whole
synthesi
mainli
take
place
perivascular
inflammatori
infiltr
cn
parenchyma
bcell
traffic
lineag
across
bloodbrainbarri
yet
describ
review
common
technic
pitfal
updat
pend
question
field
moreov
sinc
hiv
infect
associ
intrathec
chronic
oligoclon
mostli
nonspecif
ig
synthesi
associ
lowgrad
axon
lesion
could
interest
model
chronic
intrathec
synthesi
occur
multipl
sclerosi
brain
invas
hiv
occur
earli
event
take
place
primari
infect
davi
et
al
gray
et
al
gray
et
al
hassin
et
al
first
involv
hivinfect
cell
cross
bloodbrainbarri
bbb
davi
et
al
martinblondel
et
al
hiv
infect
perivascular
macrophag
microglia
koenig
et
al
martinblondel
et
al
inflammatori
cytokin
secret
infect
cell
increas
permeabl
bbb
two
main
mechan
may
involv
central
nervou
system
cn
complic
direct
viral
infect
cn
cell
initi
cascad
immun
reaction
control
viral
replic
lead
bystand
cn
lesion
opportunist
infect
lymphoma
complic
prolong
immun
suppress
evolv
consequ
larg
rang
cognit
disord
associ
hiv
appropri
drug
made
avail
proport
involv
patient
markedli
increas
diseas
stage
antinori
et
al
exampl
asymptomat
hivinfect
patient
suffer
neuropsycholog
np
impair
antinori
et
al
cdc
stage
b
c
proport
cognit
impair
rise
antinori
et
al
highli
activ
antiretrovir
therapi
haart
combin
sever
drug
introduc
end
offer
new
way
control
viral
infect
therebi
prevent
complic
prolong
immun
suppress
occur
dramat
modifi
cours
diseas
prehaart
era
hivassoci
neurocognit
disord
hand
mainli
occur
patient
count
owe
confound
opportunist
complic
moreov
high
burden
opportunist
infecti
complic
made
analysi
difficult
howev
even
haart
era
hand
may
occur
patient
normal
count
low
plasma
viral
load
antinori
et
al
heaton
et
al
although
risk
develop
hand
decreas
haart
era
preval
hiv
infect
also
increas
owe
longer
surviv
increas
age
surviv
patient
occurr
brain
lesion
haarttreat
patient
wellcontrol
count
appear
paradox
led
notion
short
cn
escap
blip
howev
cognit
impair
also
occur
excess
cohort
avirem
patient
highli
select
exclud
confound
factor
ie
illicit
drug
abus
psychiatr
opportunist
histori
simioni
et
al
even
recent
cohort
wellcontrol
patient
progress
atrophi
occur
earli
still
evid
basal
ganglia
cortex
brain
metabolit
diffus
chang
chiang
et
al
becker
et
al
kallianpur
et
al
kallianpur
et
al
ragin
et
al
towgood
et
al
gongvatana
et
al
burden
cognit
impair
even
patient
haart
without
demonstr
viral
replic
cerebrospin
fluid
csf
suggest
specif
mechan
trigger
cn
sever
trial
assess
neuroprotect
drug
target
variou
pathway
set
even
optim
control
hivinfect
patient
review
simioni
et
al
simioni
et
al
hiv
noncytopath
viru
replic
host
cell
without
interf
process
essenti
cellular
surviv
mostli
fail
infect
cell
cn
lineag
oligodendrocyt
astrocyt
neuron
instead
cn
diseas
mostli
due
chronic
immun
activ
respons
infect
commonli
observ
mani
anim
model
neurotrop
viral
infect
subaksharp
et
al
mokhtarian
et
al
mecha
et
al
furthermor
compartment
immun
reaction
trigger
hiv
infect
share
mani
aspect
reaction
observ
ms
intrathec
secret
oligoclon
antibodi
local
prolifer
lymphocyt
microgli
activ
progress
brain
atrophi
salient
featur
disord
although
progress
ms
hiv
hand
dramat
differ
caus
appear
plausibl
may
trigger
nonspecif
compartment
immun
reaction
final
lead
least
partli
common
degen
pathway
tabl
howev
full
cascad
mechan
lead
hand
remain
elucid
hong
bank
common
neurolog
practic
obviou
aspect
hiv
infect
cn
earli
trigger
lifelong
sustain
intrathec
immun
reaction
indistinguish
intrathec
synthesi
observ
pure
autoimmun
disord
like
multipl
sclerosi
ms
review
focus
evid
concern
intrathec
bcell
reaction
ig
synthesi
hiv
infect
examin
unansw
question
light
knowledg
obtain
field
cn
autoimmun
cn
infect
occur
earli
event
probabl
entri
trojan
hors
hijack
viru
brain
macrophag
microglia
infect
serv
sanctuari
csf
viral
load
strongli
correl
expans
perivascular
macrophag
human
anim
fischersmith
et
al
neg
correl
cell
infiltr
contrari
lymphoid
tissu
mccrossan
et
al
hivinfect
cell
remain
rare
undetect
brain
asymptomat
patient
tavazzi
et
al
phylogenet
studi
brain
virus
reveal
canon
mutat
underli
drug
resist
noncanon
mutat
may
compartment
brain
area
hiv
clone
virtual
privat
area
smit
et
al
stam
et
al
phenomenon
observ
patient
independ
underli
neurolog
sign
csf
hiv
decay
follow
initi
therapi
combin
two
main
mechan
rapid
decay
halflif
day
correspond
end
immigr
infect
shortliv
tcell
come
blood
absenc
detect
cnscompartment
viral
product
chronic
infect
patient
slower
decay
halflif
day
correspond
clearanc
perivascular
macrophag
infect
compartment
hiv
variant
harrington
et
al
schnell
et
al
howev
csf
escap
may
occur
otherwis
wellcontrol
hiv
infect
undetect
plasma
hiv
rna
haart
regimen
may
cooccur
progress
neurolog
involv
peluso
et
al
case
high
level
hiv
rna
copi
found
csf
often
associ
multipl
resist
mutat
canestri
et
al
peluso
et
al
mri
reveal
nonspecif
subcort
tabl
technic
recommend
specif
ig
level
csf
translat
standard
dilut
curv
antibodi
concentr
longer
express
optic
densiti
od
bukasa
et
al
reiber
lang
given
q
igg
correctli
calcul
od
ratio
simultan
assay
csf
serum
sampl
express
csfserum
ratio
circumv
arbitrari
use
unit
ig
level
csf
depend
bbb
permeabl
igg
detect
csf
bloodborn
due
passiv
diffus
even
basal
level
intrathec
igg
synthesi
alway
assess
use
q
igg
q
alb
reiber
peter
specif
intrathec
synthesi
assess
use
q
spec
allow
calcul
antibodi
index
ai
specif
fraction
f
jacobi
et
al
control
patient
intrathec
synthesi
complet
devoid
patholog
associ
intrathec
synthesi
ie
multipl
sclerosi
exampl
ms
patient
display
intrathec
synthesi
gondii
part
nonspecif
polyclon
reaction
wildemann
et
al
cerebellar
lesion
brain
biopsi
confirm
presenc
dens
perivascular
lymphocyt
infiltr
white
matter
extens
surround
parenchyma
intermingl
matur
immatur
b
lymphocyt
predomin
peluso
et
al
followup
avail
clinic
radiolog
symptom
improv
patient
csf
hiv
rna
level
decreas
week
follow
drug
adjust
canestri
et
al
peluso
et
al
howev
csf
escap
also
observ
patient
receiv
drug
good
cn
penetr
latter
case
due
independ
acquisit
drug
resist
csf
autonom
local
replic
resist
strain
canestri
et
al
eden
et
al
illustr
longer
time
haart
csf
escap
patient
treatment
interrupt
eden
et
al
bbb
impair
found
treat
patient
untreat
patient
calcagno
et
al
main
predictor
low
nadir
high
compartment
viral
replic
higher
intrathec
igg
synthesi
calcagno
et
al
given
two
latter
paramet
intim
link
plasma
hiv
load
correl
intrathec
immun
paramet
yilmaz
et
al
sinc
proport
bbb
impair
increas
along
hiv
enceph
opportunist
complic
bystand
lesion
bbb
inflammatori
respons
may
occur
infect
pericyt
decreas
express
tight
junction
disrupt
endotheli
layer
report
complet
microanatom
explan
bbb
impair
still
lack
awan
et
al
hill
et
al
whatev
exact
mechan
main
biolog
consequ
bbb
impair
concentr
bloodborn
igg
csf
increas
measur
intrathec
synthes
igg
csf
difficult
see
fig
wide
describ
variou
patholog
bbb
impair
alway
assess
csf
studi
reiber
lang
reiber
peter
direct
measur
csf
level
variou
product
unless
complet
absent
serum
without
normal
bbb
permeabl
would
give
inappropri
result
technic
pitfal
avoid
tabl
igg
index
elev
patient
chiodi
et
al
kaiser
et
al
mcarthur
et
al
singer
et
al
gisslen
et
al
recent
studi
mean
igg
index
normal
hiv
asymptomat
patient
elev
hand
patient
lackner
et
al
howev
even
median
igg
index
normal
cohort
proport
patient
abnorm
igg
index
abdul
et
al
igg
index
global
stabl
elovaara
et
al
slowli
increas
three
stage
less
one
year
mean
igg
index
mainli
normal
year
increas
year
reach
andersson
et
al
marshal
et
al
van
wielink
et
al
possibl
decreas
revers
intrathec
secret
may
occur
late
profound
immunosuppress
elovaara
et
al
marshal
et
al
singer
et
al
gisslen
et
al
unless
patient
neurolog
symptomat
elovaara
et
al
howev
crosssect
studi
proport
patient
abnorm
igg
index
secret
oligoclon
band
ocb
remain
roughli
stabl
throughout
walter
reed
stage
marshal
et
al
intrathec
synthesi
polyclon
oligoclon
stronger
igg
stain
csf
match
sera
resnick
et
al
chiodi
et
al
ocb
present
hivinfect
patient
sensit
method
use
chiodi
et
al
mcarthur
et
al
singer
et
al
gisslen
et
al
serial
tabl
hiv
infect
toward
human
model
chronic
inflamm
uniqu
human
infect
associ
chronic
cn
inflamm
chronic
longstand
intrathec
igg
synthesi
oligoclon
band
hivinduc
cn
inflamm
nonspecif
hiv
natur
histori
flush
cn
compart
complet
control
infect
haart
tabl
pend
question
intrathec
igm
synthesi
occur
hiv
infect
intrathec
igg
synthesi
suppress
longterm
csf
hiv
erad
confirm
ultrasensit
pcr
infect
trigger
sustain
selfloop
immun
reaction
cn
intrathec
nondiseaserel
csf
igg
synthesi
ie
mrz
pattern
realli
occur
hiv
infect
ms
nonspecif
igg
synthesi
appar
support
antigendriven
affin
matur
synthesi
nonrelev
antigen
ie
mrz
pattern
commonli
observ
ms
also
occur
hivinfect
patient
cnsresid
iggsecret
cell
mainli
situat
white
matter
parenchyma
basal
ganglia
leptomening
plasma
cell
isol
associ
lymphoid
structur
tertiari
lymphoid
organ
tlo
present
cn
hivinfect
patient
igg
affin
matur
occur
cn
cell
migrat
bbb
traffic
twoway
chronic
specificnonspecif
intrathec
igg
synthesi
play
role
pathophysiolog
cn
lesion
slowrat
chronic
cn
lesion
around
iggsecret
cell
infiltr
cn
infiltr
plasma
cell
therefor
local
igg
synthesi
correl
basal
ganglia
cortic
atrophyles
observ
mri
chiang
et
al
typic
marker
oxid
injuri
oxid
phospholipid
iron
occur
ms
also
recov
anim
model
coronaviru
infect
make
chronic
viral
infect
interest
model
progress
ms
lesion
schuh
et
al
besid
mimick
aspect
ms
patholog
coronaviru
model
also
character
major
intrathec
igg
synthesi
ms
patholog
hiv
infect
dorri
et
al
schwender
et
al
could
oxid
marker
also
recov
chronic
cn
viral
infect
human
hiv
subpial
lesion
observ
ms
spatial
correl
mening
tlo
also
exist
associ
mening
tlo
hiv
infect
lesion
reveal
antimbp
antiplp
immunochemistri
classic
stain
et
al
subpial
lesion
never
describ
research
aid
patient
pml
vicin
macroscop
pml
lesion
moll
et
al
unfortun
pml
aid
probabl
preclud
cortic
immun
reaction
owe
profound
immun
suppress
studi
wellcontrol
hiv
patient
would
relev
gener
intrathec
immun
reaction
associ
hiv
infect
throw
light
chronic
autoimmun
intrathec
disord
like
ms
examin
year
reveal
oneyear
latenc
infect
appear
ocb
goudsmit
et
al
andersson
et
al
number
ocb
increas
durat
hiv
infect
andersson
et
al
vari
relat
igg
index
chiodi
et
al
hagberg
et
al
daili
intrathec
igg
synthesi
tourtellott
mg
mg
posit
correl
cognit
impair
singer
et
al
result
line
obtain
ms
intrathec
igg
synthesi
rate
mgday
tourtellott
et
al
igg
index
commonli
rang
reiber
et
al
free
light
chain
often
elev
igg
index
ocb
conflict
result
preval
lambda
kappa
flc
ratio
gallo
et
al
grimaldi
et
al
level
free
light
chain
csf
compar
even
higher
ms
patient
fagnart
et
al
elovaara
et
al
remain
stabl
throughout
stage
haart
elovaara
et
al
compon
mhci
molecul
marker
immun
activ
mainli
driven
bcell
load
observ
high
level
untreat
hivinfect
csf
level
increas
linearli
mgl
cell
count
decreas
abruptli
rise
latter
drop
lucey
et
al
csf
level
quickli
normal
haart
initi
patient
abdul
et
al
igg
index
csf
igg
concentr
proport
csf
level
lucey
et
al
patient
intrathec
produc
igg
fraction
correl
hiv
load
csf
cepok
et
al
patient
followedup
longitudin
year
antiretrovir
initi
proport
elev
igg
index
slightli
decreas
abdul
et
al
less
yilmaz
et
al
count
normal
blood
hiv
rna
lower
howev
hiv
clearanc
csf
incomplet
studi
sinc
median
log
csf
hiv
rna
decreas
abdul
et
al
older
method
lack
sensit
use
case
eden
et
al
longitudin
data
acquir
ultrasensit
pcr
upon
intrathec
igg
synthesi
hiv
patient
free
csf
hiv
replic
year
still
lack
complet
suppress
intrathec
igg
synthesi
longterm
followup
hivrna
csffree
patient
may
expect
data
yet
avail
tabl
intrathec
secret
specif
hiv
protein
found
variabl
frequenc
goudsmit
et
al
chiodi
et
al
chiodi
et
al
grimaldi
et
al
kaiser
et
al
lolli
et
al
goswami
et
al
fainardi
et
al
intrathec
igg
ocb
synthesi
hiv
occur
patient
bukasa
et
al
chiodi
et
al
mcarthur
et
al
singer
et
al
gisslen
et
al
fainardi
et
al
ocb
hiv
antigen
detect
immunoblot
bukasa
et
al
dorri
et
al
kaiser
et
al
igg
hiv
antibodi
index
elev
major
patient
hivrna
recov
csf
igg
hiv
specif
index
correl
weakli
igg
index
correl
better
advanc
stage
diseas
chiodi
et
al
emskoett
et
al
sonnerborg
et
al
fainardi
et
al
seri
unselect
hivinfect
patient
intrathec
synthesi
demonstr
ocb
iefami
antigen
aihiv
intrathec
synthesi
env
detect
patient
high
level
synthesi
may
occur
associ
normal
igg
index
goudsmit
et
al
local
synthesi
antitat
antibodi
detect
csf
hiv
patient
case
earli
first
year
local
secret
calcul
rodriguez
et
al
bachani
et
al
multipl
serum
sampl
year
demonstr
mostli
stabl
antitat
respons
persist
remain
either
posit
neg
wherea
chang
reactiv
time
rodriguez
et
al
antitat
level
correl
posit
normal
cognit
wherea
lower
antitat
level
associ
hand
bachani
et
al
may
interpret
protect
action
antitat
neutral
tatmedi
neurotox
prospect
cohort
antitat
seroneg
patient
antitat
seroposit
patient
progress
aid
rodriguez
et
al
unfortun
data
gather
csf
antitat
statu
rodriguez
et
al
specif
antibodi
hiv
sometim
antibodydepend
cell
cytotox
adcc
activ
emskoett
et
al
intrathec
secret
antihiv
antibodi
direct
env
develop
asymptomat
stage
occur
almost
patient
persist
wherea
reaction
pol
gag
slightli
decreas
later
stage
chiodi
et
al
lolli
et
al
goswami
et
al
elovaara
et
al
fainardi
et
al
result
assay
cultur
supernat
free
cell
recov
csf
show
igg
reactiv
env
antigen
amadori
et
al
pattern
ocb
compar
antihiv
igg
numer
antiigg
appear
antihiv
band
wherea
faint
igg
band
depict
strong
antihiv
specif
bukasa
et
al
fig
intrathec
hivspecif
igg
synthesi
repres
small
part
igg
synthesi
occur
cn
first
studi
base
quantit
elisa
assay
proport
intrathec
synthesi
direct
hiv
antigen
estim
resnick
et
al
recent
method
use
specif
fraction
f
formula
take
account
passiv
diffus
specif
igg
blood
csf
jacobi
et
al
express
percentag
f
ratio
intrathec
synthes
igg
fraction
direct
specif
antigen
total
intrathec
synthes
igg
hand
formula
f
express
percentag
nonspecif
intrathec
synthes
igg
exampl
f
valu
hiv
mean
total
intrathec
igg
synthesi
direct
hiv
wherea
igg
direct
appli
method
first
time
patient
raw
data
provid
resnick
et
al
obtain
f
hiv
low
result
compar
f
obtain
variou
cn
disord
hsv
hsv
enceph
hsve
measl
subacut
sclerosi
panenceph
sspe
conrad
et
al
jacobi
et
al
vzv
enceph
otto
et
al
consequ
intrathec
igg
synthesi
associ
immun
respons
cn
viral
infect
appear
nonspecif
intrathec
produc
igg
rang
f
respons
even
lower
hiv
infect
cn
infect
fig
frequenc
hivspecif
b
cell
low
blood
hivinfect
patient
plasma
blood
mononuclear
cell
iggsecret
cell
reactiv
hiv
review
doriaros
connor
logic
sinc
cn
normal
devoid
igg
synthesi
far
higher
proport
hivigsecret
cell
may
expect
csf
compart
hiv
infect
cn
although
count
avail
low
f
valu
hiv
suggest
proport
hivspecif
cell
larg
cn
igg
synthesi
origin
cnsresid
iggsecret
cell
csf
float
cell
flow
cytometri
csf
float
cell
reveal
compar
distribut
cell
plasma
cell
hivinfect
patient
control
wherea
b
cell
significantli
elev
cepok
et
al
compar
control
b
cell
elev
vs
plasmablast
vs
plasma
cell
vs
cepok
et
al
plasmablast
slightli
numer
untreat
patient
cepok
et
al
csf
hiv
viral
load
correl
plasmablast
bcell
recruit
csf
cepok
et
al
extent
intrathec
synthesi
correl
csf
plasmablast
patient
andersson
et
al
cepok
et
al
haart
initi
associ
disappear
hiv
load
regress
csf
plasmablast
spudich
et
al
cepok
et
al
although
igg
index
remain
elev
abdul
et
al
yilmaz
et
al
sinc
csf
plasmablast
disappear
haart
initi
wherea
csf
igg
synthesi
mostli
preserv
iggsecret
cell
respons
intrathec
igg
synthesi
probabl
resid
within
cn
inflammatori
infiltr
note
fate
parenchym
inflammatori
infiltr
haart
initi
fulli
understood
although
float
csf
bcell
commonli
thought
respons
intrathec
synthesi
igg
low
number
iggsecret
cell
account
bulk
synthes
igg
plasma
cell
estim
secret
around
igg
lifter
et
al
amanna
slifka
gomez
et
al
igg
molecular
weight
kda
mean
white
cell
count
csf
hiv
csf
subset
plasma
cell
plasmablast
respect
cepok
et
al
result
higher
estim
daili
igg
synthes
csf
rang
mg
far
estim
base
tourtellott
formula
mgd
cn
singer
et
al
mean
bulk
igg
synthesi
provid
resid
iggsecret
cell
resid
either
mening
perivascular
area
infiltr
cn
activ
bcell
known
occur
low
level
bcellcm
parenchyma
immun
surveil
purpos
never
involv
perivascular
area
anthoni
et
al
plasma
cell
never
observ
normal
brain
parenchyma
asymptomat
hiv
infect
mild
focal
lymphocyt
infiltr
occur
around
leptomening
around
white
matter
vessel
mainli
compos
tcell
occasion
parenchym
perivascular
bcell
bcellcm
anthoni
et
al
cours
aid
parenchym
bcell
infiltr
decreas
virtual
absenc
bcell
parenchym
perivascular
infiltr
anthoni
et
al
contradict
persist
intrathec
igg
synthesi
decreas
lymphocyt
count
observ
normal
brain
parenchyma
outsid
primari
brain
lymphoma
lesion
aid
patient
anthoni
et
al
howev
subpopul
aid
patient
associ
lymphoma
demonstr
high
level
diffus
pleomorph
infiltr
plasmacytoid
bcell
perivascular
area
bcellcm
parenchyma
bcellscm
perivascular
area
anthoni
et
al
preferenti
locat
iggsecret
cell
explicitli
report
correl
igg
synthesi
class
switch
occur
mainli
ms
lambin
et
al
greve
et
al
less
select
hiv
switch
occur
extent
index
elev
lambin
et
al
elovaara
et
al
data
obtain
peripher
bcell
igg
demonstr
preferenti
mutat
pattern
heavi
chain
characterist
antigendriven
affin
matur
clonal
select
expect
viral
infect
margolin
et
al
unfortun
data
avail
date
intim
clonal
analysi
bcell
lineag
csf
brain
hiv
patient
unlik
ms
patient
harp
et
al
wing
et
al
owen
et
al
csf
bcell
clonal
analyz
singl
hiv
patient
bcell
clonal
homolog
closest
germlin
repres
point
mutat
line
antigendriven
extens
somat
mutat
process
owen
et
al
unknown
whether
extens
lineag
analysi
iggvh
would
reveal
cluster
clonal
relat
bcell
csf
cervic
lymph
node
andor
blood
whether
would
confirm
bidirect
exchang
across
bbb
alreadi
shown
ms
von
budingen
et
al
preliminari
result
confirm
complement
larger
seri
hivinfect
patient
moreov
mani
fundament
question
remain
unansw
enrich
v
h
gene
observ
hivspecif
bcell
recov
blood
data
avail
regard
cn
cell
doriaros
connor
somat
hypermut
preferenti
mutat
target
rgywwrci
motif
cdr
heavi
chain
typic
target
enzym
activationinduc
cytidin
deaminas
affin
matur
process
replac
silent
r
ratio
cdr
fdr
fragment
typic
antigendriven
clonal
select
studi
cn
bcell
knowledg
would
major
interest
demonstr
intrathec
bcell
matur
process
antigendriven
affin
matur
clonal
expans
bcell
usual
occur
primari
secondari
lymphoid
organ
may
also
occur
tertiari
lymphoid
organ
humbi
et
al
neyt
et
al
structur
recov
mening
ms
patient
might
account
intrathec
igg
synthesi
occur
ms
bonnan
haugen
et
al
date
structur
observ
cn
hiv
infect
hiv
brain
never
explicitli
examin
therefor
still
unknown
whether
intrathec
iggsecret
cell
bloodborn
matur
insid
cn
although
associ
hypothes
like
serum
hypergammaglobulinemia
common
find
hiv
infect
either
monoclon
oligoclon
polyclon
konstantinopoulo
et
al
oligoclon
pattern
present
serum
patient
sensit
techniqu
like
isoelectrofocus
use
laurijssen
et
al
del
bono
et
al
synthesi
commonli
attribut
hivinduc
nonspecif
bcell
activ
due
tcell
deplet
virusinduc
immun
hyperactiv
mostli
littl
clinic
consequ
coker
et
al
qualit
data
nonspecif
intrathec
synthesi
yet
extens
examin
could
attribut
synthesi
autoantigen
opportunist
infecti
agent
broad
nonhivrel
infecti
agent
might
even
due
antigendriven
antibodi
histor
point
view
possibl
coexist
intrathec
synthesi
nondiseaserelev
viru
like
measl
consid
unlik
older
paper
either
exclud
patient
inappropri
use
ratio
igg
csf
igg
serum
measl
normal
data
passiv
diffus
lloyd
et
al
mathiesen
et
al
van
wielink
et
al
moreov
aid
character
profound
immun
suppress
imped
even
abolish
capac
develop
immun
reaction
opportunist
infect
exampl
intrathec
synthesi
toxoplasma
gondii
may
abolish
cn
toxoplasmosi
aid
contradictori
result
obtain
differ
studi
chiodi
et
al
specif
synthesi
gondii
confirm
half
toxoplasm
enceph
patient
potasman
et
al
frequenc
mrz
pattern
measl
rubella
zoster
thought
absent
hiv
infect
almost
absent
acut
cn
infect
review
bonnan
wherea
present
ms
patient
et
al
jariu
et
al
nevertheless
use
older
methodolog
seri
hiv
patient
found
intrathec
synthesi
measl
patient
cmv
patient
mathiesen
et
al
anoth
seri
patient
antibodi
measl
hsv
vzv
cmv
gondii
detect
immunofix
sera
csf
patient
without
intrathec
synthesi
except
one
patient
minor
secret
vzv
chiodi
et
al
use
optim
methodolog
reiber
et
al
studi
two
hiv
patient
found
mrz
pattern
one
display
intrathec
synthesi
hsv
reiber
peter
seri
patient
intrathec
synthesi
demonstr
hiv
rubella
hsv
vzv
cmv
buffet
et
al
suggest
nonspecif
pattern
could
common
could
major
theoret
import
studi
mrz
pattern
context
sinc
hiv
offer
uniqu
opportun
investig
chronic
intrathec
inflamm
last
year
even
decad
toxoplasm
enceph
aid
intrathec
synthesi
gondii
asi
observ
patient
local
oligoclon
synthesi
high
antibodi
index
persist
recoveri
contini
et
al
borg
figueiredo
free
light
chain
show
local
oligoclon
band
kappa
type
patient
lambda
type
patient
band
demonstr
specif
toward
gondii
antigen
contini
et
al
note
mani
articl
even
recent
one
use
inappropri
judgment
criteria
intrathec
synthesi
meira
et
al
howev
aid
patient
intrathec
synthesi
ongo
opportunist
infect
may
occur
diagnosi
may
challeng
syphilisinfect
hiv
patient
display
neg
csfvdrl
level
csf
may
highli
sensit
marra
et
al
intrathec
synthesi
cmv
antigen
occur
unselect
hiv
patient
prehaart
rang
cmv
lesion
observ
autopsi
weber
et
al
patient
die
cmv
enceph
patholog
confirm
also
commonli
fail
mount
intrathec
ig
respons
weber
et
al
therefor
synthesi
may
interpret
scar
past
cmv
infect
rather
nonspecif
synthesi
antimog
antibodi
report
csf
serum
hiv
patient
lackner
et
al
followup
pattern
antimog
synthesi
variabl
antimog
titer
csf
viral
load
clearanc
follow
initi
haart
may
evolv
either
sharp
increas
stabl
titer
along
month
year
late
slow
decreas
csf
titer
lackner
et
al
discord
csf
viral
clearanc
antimog
antibodi
titer
suggest
initi
csf
hiv
infect
immunolog
mechan
drive
intrathec
synthesi
mainli
independ
sustain
csf
infect
lackner
et
al
mani
antibodi
report
csf
hiv
patient
igg
igm
sulfatid
mbp
mbp
fragment
cerebellar
solubl
lectin
mathiesen
et
al
hagberg
et
al
de
gasperi
et
al
gisslen
et
al
wherea
antisulfatid
could
found
csf
other
gisslen
et
al
mention
intrathec
synthesi
specif
antibodi
explicitli
calcul
mani
studi
although
q
alb
remain
low
one
complet
exclud
passiv
diffus
blood
mathiesen
et
al
hagberg
et
al
gisslen
et
al
gisslen
et
al
lackner
et
al
remain
major
theoret
import
studi
possibl
intrathec
synthesi
autoantigen
use
unbias
techniqu
make
definit
conclus
perivascular
infiltr
heterogen
domin
tcell
perivascular
area
wherea
bcell
present
low
proport
petito
et
al
petito
et
al
gray
et
al
one
question
whether
perivascular
tcell
randomli
infiltr
cell
origin
blood
result
local
antigendriven
clonal
expans
tcell
lin
et
al
sequenc
tcr
transcript
brain
perivascular
tcell
confirm
massiv
oligoclon
wherea
transcript
recov
normal
blood
donor
alway
uniqu
lin
et
al
none
identifi
tcr
sequenc
previous
identifi
known
react
hiv
interestingli
clone
exhibit
substanti
homolog
clone
direct
mbpand
tetanu
toxoidspecif
class
ii
restrict
tcell
clone
tcell
clone
isol
ms
plaqu
patient
rasmussen
enceph
lin
et
al
substanti
homolog
mbpspecif
tcr
present
sequenc
lin
et
al
clone
present
one
patient
exhibit
myelin
pallor
observ
patient
moreov
patient
exhibit
clone
mbp
also
share
common
classic
hla
one
amino
acid
differ
lin
et
al
consequ
tcell
infiltr
blood
vessel
brain
pediatr
patient
may
autoimmun
rather
antivir
cell
clone
inflammatori
respons
associ
low
hiv
viral
load
infiltr
cell
associ
multinucl
giant
cell
data
lack
confirm
whether
clonal
expand
mbpspecif
tcell
clone
may
attribut
epitop
spread
besid
immunoglobulin
cytokin
produc
intens
cn
hiv
infect
although
unclear
local
synthes
cytokin
contribut
cn
patholog
grow
set
evid
suggest
particip
lesion
ie
enceph
vacuolar
myelopathi
tyor
et
al
kobayashi
et
al
saha
pahan
briefli
review
main
cytokin
involv
lymphocyt
traffic
macrophag
activ
axon
lesion
marker
chemokin
ligand
express
tcell
nkcell
act
major
chemoattractor
inflammatori
condit
level
csf
consist
elev
hiv
patient
whatev
stage
involv
lymphocyt
count
promot
recruit
infect
tcell
csf
kolb
et
al
cinqu
et
al
spudich
anc
bremel
et
al
paradox
effect
may
therefor
promot
amplif
csf
infect
via
import
infect
tcell
via
trojan
hors
mechan
cinqu
et
al
csf
level
normal
less
week
treatment
initi
although
csf
hiv
rna
remain
elev
treatment
interrupt
csf
level
increas
day
cinqu
et
al
csf
elev
far
lower
hiv
infect
neurosyphili
hiv
patient
lyme
infect
nonhiv
patient
high
level
may
sensit
specif
surrog
marker
associ
infect
marra
et
al
bremel
et
al
associ
secondarytertiari
lymphoid
organ
elev
serum
hivinfect
patient
yet
investig
csf
dama
et
al
elev
csf
cell
found
perivascular
cell
microglia
basal
ganglia
parenchyma
gray
white
matter
howev
cell
mainli
associ
sever
case
hivassoci
cognit
motor
complex
seilhean
et
al
futur
trial
involv
monoclon
antibodi
deserv
consider
del
palacio
et
al
neopterin
marker
macrophag
activ
elev
csf
patient
whatev
csf
viral
load
yilmaz
et
al
spudich
anc
followup
treatment
initi
neopterin
progress
normal
patient
one
two
year
respect
abdul
et
al
yilmaz
et
al
longterm
studi
patient
receiv
haart
perfectli
control
csf
serum
hiv
rna
b
copiesml
year
provid
evid
persist
immun
activ
eden
et
al
although
csf
hiv
rna
undetect
csf
wbc
normal
neopterin
low
still
abnorm
patient
eden
et
al
igg
index
still
elev
patient
haart
compar
rang
haart
eden
et
al
studi
base
ultrasensit
pcr
techniqu
neopterin
lowest
group
patient
without
csf
hiv
rna
yilmaz
et
al
yilmaz
et
al
howev
remain
abnorm
virolog
wellsuppress
copiesml
patient
even
year
complet
viral
control
yilmaz
et
al
yilmaz
et
al
suggest
although
complet
control
intrathec
infect
appar
obtain
lowgrad
immun
activ
persist
cn
recent
studi
use
singlecopi
assay
patient
haart
patient
csf
hiv
rna
dahl
et
al
howev
blip
detect
csf
hiv
rna
occur
patient
multipl
sampl
interestingli
blip
associ
slight
transient
increas
csf
neopterin
dahl
et
al
suggest
goal
complet
viral
suppress
still
attain
persist
immunoactiv
might
mean
lowlevel
viral
replic
may
still
occur
csf
limit
detect
ultrasensit
pcr
techniqu
copiesml
possibl
may
link
persist
immunoactiv
silent
transient
csf
viral
escap
longterm
followup
elit
control
known
durat
infect
year
csf
concentr
neopterin
rang
hivneg
control
patient
probasco
et
al
howev
sinc
patient
spontan
control
probabl
never
develop
cn
hivinfect
even
haart
era
consequ
absenc
csf
inflamm
patient
may
better
interpret
spontan
resist
establish
csfcn
inflamm
proof
vanish
earlier
inflammatori
state
still
unknown
whether
prolong
persist
intrathec
lowgrad
immun
activ
harm
yilmaz
et
al
kinet
csf
chang
studi
patient
stop
combin
antiretrovir
therapi
plasma
hiv
load
first
increas
follow
week
increas
csf
hiv
load
increas
csf
white
cell
damag
marker
neopterin
neurofila
lag
csf
viral
replic
neuron
damag
measur
nfl
suggest
evolv
immunopatholog
process
initi
surg
viral
replic
neurofila
nfl
marker
axon
degener
found
increas
csf
hivinfect
patient
immun
suppress
increas
patient
normal
count
patient
jessen
krut
et
al
nfl
level
far
higher
hiv
dementia
nondement
hiv
patient
jessen
krut
et
al
interestingli
increas
nfl
level
csf
alway
preced
clinic
present
decreas
month
treatment
initi
half
patient
month
three
quarter
year
abdul
et
al
mellgren
et
al
jessen
krut
et
al
haart
csf
nfl
level
decreas
patient
normal
even
adjust
age
jessen
krut
et
al
data
obtain
anim
model
owe
rel
resist
anim
hiv
brain
infect
poor
model
hiv
enceph
suitabl
viralinduc
demyelin
hiv
infect
rodent
natur
condit
promis
model
base
immunedeplet
mice
repopul
human
hematopoiet
stem
cell
gorantla
et
al
although
murin
immunopatholog
differ
human
sinc
human
mice
lack
human
stromal
cell
gorantla
et
al
model
provid
good
approach
hiv
enceph
anim
show
cognit
defect
brain
macrophag
infect
hiv
dendrit
arbor
neuron
surround
infect
macrophag
microglia
decreas
assum
opportunist
infect
never
occur
sa
et
al
data
avail
cn
igg
synthesi
model
simian
immunodefici
syndrom
siv
infect
caus
aidslik
syndrom
rhesu
macaqu
macacca
mulatta
smith
et
al
infect
brain
tissu
demonstr
pcr
day
postinocul
constant
day
although
infect
cell
rare
observ
situ
hybrid
milush
et
al
death
intrathec
synthesi
demonstr
elev
igg
index
synthesi
sivspecif
igg
smith
et
al
howev
sivinfect
macaqu
die
noncn
disord
shortli
inocul
mean
day
patholog
lesion
cn
undemonstr
smith
et
al
differ
studi
longitudin
analyz
csf
inocul
igg
index
strongli
increas
week
sharpli
decreas
even
normal
thereaft
quinolin
acid
csf
concentr
peak
week
normal
smith
et
al
anim
sacrif
week
mening
glial
nodul
perivascular
cuff
mononuclear
cell
smith
et
al
rhesu
macaqu
infect
viral
isol
classic
neurolog
sign
associ
aid
appear
group
rapid
slow
progressor
sopper
et
al
intrathec
igg
synthesi
observ
week
virusspecif
antibodi
env
et
gag
recov
csf
sopper
et
al
interestingli
rapid
progressor
demonstr
virusspecif
ig
respons
wherea
csf
respons
slow
progressor
parallel
serum
respons
sopper
et
al
envspecif
antibodi
secret
cell
account
cnsderiv
plasma
cell
seem
stabil
around
correspond
envspecif
cn
plasma
cell
per
brain
sopper
et
al
high
csf
viral
load
associ
rapid
progress
monkey
fail
develop
intrathec
respons
suggest
protect
role
intrathec
immun
respons
sopper
et
al
howev
find
need
replic
moreov
earlier
experi
use
show
intrathec
synthesi
antienv
start
week
infect
interestingli
earli
infus
natalizumab
shown
reduc
viral
burden
cn
macrophag
prevent
hivinfect
monocytesmacrophag
enter
brain
campbel
et
al
consequ
intrathec
synthesi
examin
could
intrathec
ig
synthesi
associ
hiv
infect
model
aspect
chronic
autoimmun
cn
inflamm
set
asid
direct
consequ
viral
infect
focu
hivinduc
chronic
cn
inflamm
three
main
aspect
consid
first
hivinfect
suffici
frequent
requir
public
health
polici
fact
last
chronic
cn
infect
tradit
infect
alreadi
disappear
thank
modern
medicin
neurosyphili
tubercul
mening
almost
disappear
wherea
neuroborreliosi
treat
earli
meningoenceph
caus
either
acut
curabl
quickli
fatal
consequ
hiv
infect
uniqu
longlast
human
model
chronic
cn
inflamm
secondli
hivinduc
cn
inflamm
complet
deciph
sinc
research
focus
pragmat
virusinduc
lesion
howev
nonspecif
immun
reaction
common
hivinfect
nonspecif
synthesi
also
common
chronic
autoimmun
cn
inflamm
case
consid
characterist
chronic
autoimmun
exampl
nonspecif
synthesi
measl
rubella
zoster
socal
mrz
reaction
characterist
occur
earli
ms
patient
never
previous
experienc
enceph
consid
serolog
scar
proport
patient
posit
mrz
increas
time
brecht
et
al
suggest
mrz
posit
nonspecif
function
time
chronic
inflamm
intrins
characterist
ms
bonnan
longstand
hivinfect
patient
provid
ideal
model
chronic
inflamm
may
provid
decis
evid
field
autoimmun
thirdli
natur
histori
untreat
hiv
immun
suppress
secondari
profound
cell
loss
lead
aid
frequent
complic
opportunist
infect
haart
almost
complet
control
hiv
infect
revers
immun
suppress
consequ
hiv
infect
aid
also
consid
experiment
situat
transient
extrem
flush
cell
cn
interestingli
monoclon
antibodi
direct
natalizumab
prevent
transmigr
tcell
cn
use
treat
ms
intrathec
igg
synthesi
mrz
secret
may
decreas
ms
patient
receiv
natalizumab
warnk
et
al
major
theoret
issu
sinc
hiv
infect
may
lower
rel
risk
multipl
sclerosi
gold
et
al
intrathec
synthesi
hiv
highli
preval
hiv
infect
even
nonneurolog
impair
patient
besid
igg
synthesi
direct
hiv
synthesi
nonspecif
observ
blood
etiolog
consequ
chronic
intrathec
reaction
unknown
rigor
studi
chronic
inflamm
without
apriori
expect
techniqu
use
multipl
sclerosi
might
avenu
worth
explor
tabl
author
declar
conflict
interest
